临床试验/NCT00689377

NCT00689377已完成不适用

Prevalence of Peripheral Arterial Disease in Subjects With a Moderate CVD Risk, With No Overt Vascular Diseases nOR diAbetes Mellitus

AstraZeneca1 个研究点分布在 1 个国家目标入组 9,000 人开始时间: 2007年5月最近更新: 2012年3月20日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: AstraZeneca
入组人数: 9,000
试验地点: 1
主要终点: Prevalence of lower extremities peripheral arterial disease (PAD), in subjects with a moderate CVD risk, with no overt cardiovascular diseases nor diabetes mellitus

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Non interventional study aimed to establish the prevalence of lower extremity peripheral arterial disease (PAD), defined as an ankle-brachial index (ABI) not above 0.90 in subjects with a moderate risk of cardiovascular disease, with no overt cardiovascular diseases nor diabetes mellitus.

研究设计

研究类型: Observational
观察模型: Case Only
时间视角: Cross Sectional

入排标准

年龄范围: 45 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Male subject aged 45 years or above, or female subject aged 55 years or above (age-related CVD risk factor)
•At least another of the following risk factor for CVD: cigarette smoking, hypertension, low HDL cholesterol or high LDL cholesterol, family history of premature coronary heart disease, elevated waist circumference
•Willingness to participate in the survey and complying with the study by signing a written informed consent

排除标准

•No or 1 risk factor for CVD; symptoms of PAD; diabetes mellitus; coronary heart disease or equivalents
•No lipid data collected in the last 12 months
•Serious or unstable medical or psychological conditions that, in the opinion of the Investigator, would compromise the subject's safety or successful participation in the study; unwilling or unable to provide informed consent

结局指标

主要结局

Prevalence of lower extremities peripheral arterial disease (PAD), in subjects with a moderate CVD risk, with no overt cardiovascular diseases nor diabetes mellitus

时间窗: 1 visit

次要结局

Determinants (i.e., subject and physician characteristics) for PAD underdiagnosis in the selected population(1 visit)
Cardiovascular risk level and risk factor treatment in the selected population assessed according to the locally adopted risk charts or algorithms(1 visit)
Prevalence of cardiovascular risk factors in subjects with at least two CVD risk factors, with no overt cardiovascular diseases nor diabetes mellitus(1 visit)

研究者

发起方

AstraZeneca

申办方类型

Industry

责任方

Sponsor

研究点 (1)

Loading locations...

相似试验

已完成

不适用

Etiology and Prevalence of Peripheral Arterial DiseaseCardiovascular DiseasesPeripheral Vascular DiseasesArterial Occlusive Diseases

NCT00005142National Heart, Lung, and Blood Institute (NHLBI)

已完成

不适用

Prevalence of peripheral arterial disease in patients with coronary artery diseaseperipheral arterial disease (peripheral artery disease of lower limb, renal artery stenosis, carotid artery stenosis and abdominal aortic stenosis)

JPRN-UMIN000002486Kokura Memorial Hospital2,000

已完成

不适用

Vastmanland Myocardial Infarction Study (VaMIS)Peripheral Artery DiseaseDiabetesAcute Myocardial Infarction

NCT01452178Uppsala University1,008

招募中

不适用

Multicenter prospective study of peripheral arterial disease treatmentSymptomatic peripheral arterial disease

JPRN-UMIN000015926Keio University Hospital Department of Surgery5,500

已完成

不适用

Peripheral Arteriopathy Rate In StrokePeripheral Artery Disease

NCT00794066University of Erlangen-Nürnberg Medical School1,500